FIELD: medicine.
SUBSTANCE: what is presented is a kit of reagents for immune-enzyme assay of the endogenous bioregulator antibodies in blood serum for detecting addiction disorders by two-site enzyme immunoassay in human blood serum in vitro. The kit comprises a 96-well demountable stripped plate with its surface sequentially coated by all conjugates: βendorphins, serotonin, dopamine, histamine, orphanin and angiotensin, as well as containers containing positive and negative reference samples, horseradish peroxidase-labeled anti-species anti-human antibodies, phosphate-buffered saline containing Tween 20, a substrate buffer solution, a tetramethyl benzidine substrate solution, and a stop solution.
EFFECT: more accurate detection of the addiction diseases, including alcoholism, drug addiction, chemical abuse, food addiction and gambling by using the kit of six labels.
3 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSMENT OF ATHLETES ADAPTATION POTENTIAL | 2018 |
|
RU2715883C2 |
| METHOD OF DETERMINING APTITUDE TO DISEASES OF DEPENDENCE | 2008 |
|
RU2369872C1 |
| METHOD FOR DIAGNOSING NARCOTIC DRUG CONSUMPTION | 2005 |
|
RU2291436C1 |
| METHOD OF EFFICIENCY CONTROL FOR POLLINOSIS SPECIFIC IMMUNOTHERAPY | 2007 |
|
RU2370774C2 |
| EXPRESS METHOD FOR DETERMINING HYPER-BETA-ENDORPHINIA IN HUMAN ORGANISM | 2006 |
|
RU2322945C1 |
| TEST SET FOR DIAGNOSING NEUROLOGIC DISEASES | 1995 |
|
RU2112243C1 |
| DRUG ADDICTION-REVEALING DIAGNOSTIC REAGENT KIT "NARCO-IFA-PEPTIDE TEST" | 2005 |
|
RU2297634C2 |
| MONOCLONAL ANTIBODY 6G1 TO MORPHINE DERIVATIVES | 2018 |
|
RU2703494C1 |
| DIAGNOSTIC KIT FOR DETECTING SCHIZOPHRENIA | 2001 |
|
RU2216741C1 |
| METHOD FOR DETERMINING NERVOUS SYSTEM PATHOLOGY RISK GROUP BY MEANS OF SCREENING AND HEALTH STATE MONITORING OF PEOPLE SUFFERING FROM NEUROPSYCHICAL DISEASES | 2003 |
|
RU2259567C2 |
